Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 51655-176

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 51655-176). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 176 84 Rev A 09 20)

Label for Diclofenac Sodium Delayed-Release Tablets, USP 75 mg, oral dosage form. The label indicates 14 tablets per package and specifies storage instructions, dosage note, and safety warnings. It is labeled by Northwind Health Company, LLC and includes product identification and lot information.*

FDA Label Image

Figure (Dic05 0006 01)

Chemical structure of Diclofenac Sodium, showing two chlorophenyl rings connected via an amino group and an acetic acid sodium salt moiety.*

FDA Label Image

Logo (Dic05 0006 04)

Diclofenac Sodium Delayed Release 75 mg film-coated tablets bottle label. The label shows the product name, strength, dosage form as delayed release tablets, the quantity count of 100 tablets, and the labeler Northwind Health Company, LLC. The bottle is orange plastic with a child-resistant cap.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.